Back to 
Alkeon Capital Management LLC
Alkeon Capital Management LLC
CYTKShowing 0 of 4 quarters
Position history for Alkeon Capital Management LLC's holdings in Cytokinetics, Incorporated
No. Alkeon Capital Management exited its CYTK (Cytokinetics) position in Q4 2020. Its Q3 2020 13F listed 300,000 shares worth $6.5M. Alkeon Capital Management first reported CYTK in Q1 2020 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC